Pfizer

Secret contracts reveal undisclosed terms in Trump's drug-pricing deals

Agreements with Pfizer and Eli Lilly include tariff protections, overseas pricing inducements and broad confidentiality clauses.

Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks

On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson &…

Pfizer Board Member Dismissed Key Natural Immunity Studies In CIA Briefing, Docs Claim

'These were the early days of COVID'

Dr. Scott Gottlieb says Trump FDA pick Heidi Overton "could be a strong candidate"

Former FDA Commissioner Dr. Scott Gottlieb, who now sits on the boards of Pfizer and United Healthcare, told "Face the Nation with Margaret Brennan" that Presi…

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

Buckling Columns on NYC Pfizer HQ May Chill Broader Office-to-Residential Conversion Trend

Structural problems with one of the largest office-to-residential conversion projects in the nation could signal hidden risks in what has been a lucrative sect…

New York construction scare shows challenges of converting offices into housing

The buckling of two steel columns at the former Pfizer headquarters in Manhattan has raised questions about one of the nation's largest office-to-apartment con…

Unstable building in Midtown Manhattan forces multiple evacuations, street closures

The unstable building is the former Pfizer headquarters in Midtown Manhattan that is being converted into apartments.

Manhattan high-rise evacuated as officials warn of potential collapse

A Midtown Manhattan office building that once had Pfizer offices was at risk of collapsing on Tuesday, prompting an emergency response.

Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?

Best Pharmaceutical Stocks To Follow Today - July 5th

Eli Lilly and Company, AbbVie, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical sto…

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.

Best Pharmaceutical Stocks To Consider - June 25th

Eli Lilly and Company, AbbVie, Abbott Laboratories, Pfizer, McKesson, Gilead Sciences, and Ascendis Pharma A/S are the seven Pharmaceutical stocks to watch tod…

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.

Dividend Stocks To Watch Now - May 10th

ProShares UltraPro Short QQQ, Chevron, Direxion Daily TSLA Bull 2X Shares, Accenture, Pfizer, AbbVie, and Comcast are the seven Dividend stocks to watch today,…

Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," May 10, 2026

The following is the transcript of the interview with former FDA Commissioner Scott Gottlieb, who is on boards the of Pfizer and UnitedHealthCare, that aired o…

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease vaccine after a late-stage tr…

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization col…

Pfizer Colorectal Cancer Trial Win Adds Weight To Oncology Turnaround Story

Pfizer (NYSE:PFE) reported positive topline results from its pivotal BREAKWATER trial. The study evaluated a BRAFTOVI based combination in previously untreated…

Pfizer (PFE) Valuation Check After Recent Share Price Rebound And Mixed Earnings Signals

Why Pfizer (PFE) is on investors' radar today Pfizer (PFE) is drawing attention after recent trading left the shares at a last close of $27.37, with returns of…

Pfizer Inc. $PFE Shares Sold by Ingalls & Snyder LLC

Ingalls & Snyder LLC trimmed its position in Pfizer Inc. (NYSE:PFE - Free Report) by 2.7% during the 3rd quarter, according to its most recent filing with the…

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration's policies on…

Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more

These are the stocks posting the largest moves in early trading.

Pfizer's stock drops after it lowers its revenue forecast

The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.

Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more

These are the stocks posting the largest moves in early trading.